Jay Hagan is the founder of Ambros Therapeutics. Ambros Therapeutics has raised $125M in total funding. Latest round: Series A.
Jay Hagan is the President, CEO, and Director of Ambros Therapeutics, a clinical-stage biotechnology company located in Irvine, California. He joined the company in December 2025 following an oversubscribed Series A financing round of $125 million. Hagan leads Ambros Therapeutics in developing non-opioid treatments for severe medical conditions.
Full founder directory · Investor directory · Company funding database · Fundraising library